Summary
A defect in chen~otaxis of peripheral blood polymorphonuclear leukocytes (PMN's) was demonstrated in both parents and three of four children in a single family afllicted with varying degrees of respiratory allergy, unusual onset of severe eczema in the first month of life, and recurrent bacterial skin infections. Of great interest was the identification of HLA-Bl2 at the B locus in all affected members but not in the unaffected child. The two children known since infancy to be most severely affected with eczema and recurrent infections are HLA identical and homozygous for HLA-Bl2. The child without eczema and infections had an intermediate cellular chemotactic defect most apparent on kinetic studies.
Speculation
Recently, several familial defects of neutrophil chemotaxis have been reported in association with syndromes of recurrent bacterial infections, reaginic hypersensitivity, and/or clinical atopy. Our studies extend these observations by describing the possible genetic relationships between atopy (e.g., eczema) chemotactic defects, and the HLA system. Future studies in this field should examine the association between chemotactic defects and the HLA system, and the requirements of both atopy and chemotactic defects to produce recurrent infections.
Migration of leukocytes to sites of inflammation and infection involves a number of complex interrelating processes which presently are poorly understood. However, each definition of a variant from normal, each "experiment of nature," may contribute to an increased understanding of these basic mechanisms and, ultimately, to more effective relief of symptoms. years and studied repeatedly during a 2.5-year period, who display a pattern of unusually severe chronic eczema, asthma, and recurrent bacterial skin infections, all starting in the first month of life. The repetitive pattern of onset of a severe dermatitis in the first month of life suggested the possibility of an immunologic deficiency. In this family, phenotypic expression of the anomaly is associated with the presence of the histocompatibility antigen HLA-B12.
CASE REPORTS

CASE I (FW)
The 46-year-old father of the four children reported below has suffered from asthma and severe eczema with lichenification all of his life. During childhood the eczema was frequently infected. He has been otherwise healthy.
CASE 2 (DW)
The 38-year-old mother of the four children reported below has suffered from asthma and mild atopic dermatitis all her life.
She has been otherwise healthy. Her marriage to FW is not consanguinous.
CASE 3 (AW)
This 16-year-old daughter of cases I and 2 has had eczema with frequent staphyloc~ccal superinfection since early infancy. Her skin is greatly lichenified. At age 15 she had osteomyletis (presumed to be staphylococcal and treated as such) of the left tibia. Over the years she has had a number of hospitalizations for asthma, and many episodes of impetiginous superinfection of her eczema. Growth. and development are normal.
Hill and Q U~ ( 6 ) first described a defect in neutrophil chemotaxis in three unrelated children with eczema, recurrent bacterial
CASE 4 (RW)
infections, and increased serum immunoglobulin E (IgE) levels. We now report our findings of a cellular chemotactic defect in
This 11-year-old son of cases 1 and 2 has had eczema and the neutrophils of five of six family members, followed for 11 asthma since early infancy with recurrent episodes of impetigi-nous supcrinfcction of the skin. Thc severe cczcma has requircd the administration of prednisone, 10 mg, on alternate mornings on arising for the past 3 years. There have been a numbcr of hospitalizations for asthma and recurrent need for treatment of staphylococcal skin infections. Developmental milestones were delayed but intelligence seems normal. Growth is normal.
CASE 5 (EW)
This 7-year-old daughter of cases I and 2 has had only mild asthma not requiring hospitalization at any time but has had eczema since early infancy with recurrent staphylococcal skin infections and impetigo. Her developmental milestones were also delayed, but she also seems of normal intelligence and has grown normally.
CASE 6 (PW)
This 12-year-old son of cases I and 2 has normal skin and has never had asthma. Developmental milcstoncs wcre normal. He has ragweed allergy with seasonal rhinitis.
MATERIALS AND METHODS
HUMORAL IMMUNITY
Immunoglobulins G , A , and M were measured quantitatively on immunoplates (19). Immunoglobulin E was measured by a radioimmunoassay technique (20) . Specific IgE antibodies to ragweed antigen were measured by the radioallcrgosorbcnt test (21) . C, complement was measured by radial immunodiffusion (22) , total hemolytic complement (CH50) by the method of Mayer (9) . Skin testing for immediate hypersensitivity was carried out using a standard panel of antigens. Isohemagglutinins were measured by standard techniques. B-cell markers wcre measured using sheep erythrocytes (E), rabbit anti-sheep erythrocyte antibody (A), and fresh mouse serum (C) (3, 8) .
CELLULAR IMMUNITY
Skin tests for delayed hypcrsensitivity employed the following materials: ( I ) Candida extract (23), 100 protein-nitrogcn units (PNU)/cc; ( 2 ) mumps (24); ( 3 ) streptokinase-streptodornase (25), 10,000 units/cc for the former and 2500 unitslcc for the latter, in a l : l 0 dilution; (4) trichophytin (23) , 500 PNU/cc; and (5) tuberculin, first strength purified protein derivative. In all cases 0.1 ml was injected intradermally and the degree of induration read at 24 and 4 8 hr.
Lymphocyte cultures employed phytohemagglutinin and pokeweed mitrogen to measure the proliferative response of the parents' peripheral blood lymphocytes (1) . All cultures were performcd in duplicate, with 1 x l O~e I l s / t u b c , cultured in 10% autologous plasma.
T-cell markers werc assessed by the rosette technique, using sheep erythrocytes (E) (3, 8) .
INFLAMMATORY RESPONSE
The cellular and humoral components of chemotaxis were studied by a previously described modification of the Boyden assay (14) . A washed suspension of either control or patient PMN's at a final concentration of 5 x 10fi/ml was placed on one side of a 3 micropore size membrane. Materials with chemotactic activity werc placed on thc other side. These materials were generated from fresh control or patient plasma or serum by incubation with performcd antigen-antibody complexes. After incubation for 3 hr at 37O the average number of PMN's per high power field reaching the lowermost surface was determined (10 contiguous high power fields were counted). All experiments were performed in duplicate, and most experiments were counted in "blind fashion" by a second observer. In several experiments, the procedure was modified to compare the migration of control and patient PMN's at different incubation timcs (30-180 min) , and the effects of preincubating control PMN's in normal or patient serum. Family members rcceived no drugs for a minimum of 1 week before study. In every experiment a normal control subject was studied on the same day as the patients. During the 2.5-year period that chcmotaxis expcriments were performed, 1 0 different normal control subjects wcre employed on different days. The mean chemotactic migration of control PMN's was 17.3 2 1.3 whcn autologous serum was the source of chemotactic factors, and 17.9 2 1.4 whcn autologous plasma was the source of chemotactic factors.
Atopic Patient Cotttrol S~cbjects. Eight unrelated children with chronic severe cczcma and varying degrees of clinical asthma and/or allergic rhinitis werc studied. All of these patients werc receiving topical corticostcroicl thcrapy; several wcrc also rccciving systemic antibiotics for bacterial infections.
Nortnal Corztrol Subjects. Healthy adult laboratory volunteers wcre used as control subjects.
Random lcukocyte mobility was mcasurcd by a modification of the method of Ketchel and Favour (13) .
The cellular and humoral components of phagocytosis of baker's yeast particles were studied by the method of Miller and Nilsson (12) . Opsonization and phagocytosis of Stnpkylococcus allreus was studied by the technique of Root and associates (16) .
Leukocyte bactericidal activity using Staphylococc~~s altreus as the tcst organism was examined by the technique of Root and associates (1 6).
Inflammatory stimulation was studied by the method of Rebuck and Crowlcy, according to previously published techniques (14) . Epinephrine stimulation of the marginal lcukocytc pool, and hydrocortisone stimulation of the bone marrow lcukocytc pool were studied by previously published techniques (14) .
HLA TYPING
H L A typing was performcd by the standard NIH two-stage microlymphocytotoxicity tcst.
RESULTS
HUMORAL AND CELLULAR IMMUNITY, HLA TYPING
The pertinent results of the studies of humoral and cellular immunity arc presented in Figure 1 , together with the family pedigree and results of HLA typing. IgE lcvcls were markedly elevated in A W , RW, and EW consistent with their history of atopy and severe eczema. The IgE level was normal in PW, who does not have eczema. Immediate hypcrsensitivity was noted in all family members to a variety of antigens, and peripheral eosinophilia was present in everyone but FW and PW. Sensitivity to ragweed antigen at a single concentration (10 PNUIml) was found by immediate skin testing in all family mcmbers, and appeared to correlate with RAST scores, but not with IgE levels. PW had the-most severe ragweed sensitivity, based on clinical symptomatology, skin tests, and RAST score.
IgG was mildly elevated in AW and RW and IgA was mildly elevated in FW. All other immunoglobulin lcvcls and C, and CH50 determinations were normal. Delayed hypersensitivity skin tests, in vitro lymphocyte proliferative responses, and numbers of circulating T-and B-cells were in the normal range.
HLA typing revealed HLA-B12 at the B locus in all family mcmbers except PW. Two of the children, A W and RW, were HLA identical and hornozygous for HLA-B 12.
INFLAMMATORY RESPONSES
With the exception of the chemotactic abnormality to be described, those humoral and cellular contributions to the inflammatory response that were tested were normal. Fig. 2 . The generation of chemotactic factors from the plasma and serum of normal control subjects, family members (patients), and eczema control subjects is compared. Normal polymorphonuclear leukocytes (PMNS) were used for each set of experiments. Each point represents the mean of duplicate determinations and group mean values are indicated by the horizontal bars. 0: plasma as a source of chemotactic factors; 0: serum as a source of chcmotactic factors; +: buffer controls (no plasma or serum added to the bottom of the chambers). HPF: high power field.
CHEMOTAXIS
Studies of this family's plasma, serum, and cellular contributions to chemotaxis were performed repeatedly over a 2.5-year period. O n one occasion, eight atopic children with severe eczema served as control subjects. Results presented in Figure 2 compare group mean values of serum and plasma chemotactic factors from normal control subjects, eczema control subjects, and family members (nonpaired t-test). Each family member had serum and/or plasma chemotactic factors measured o n at least four occasions, except E W and FW, who were tested three times. Thus, there are 22 patient studies reported. There were n o significant differences in the generation of plasma chemotactic f = Meon i l S.D.
Normal
Patients Patient Eczema controls P. W. controls Fig. 3 . The migration of polymorphonuclear leukocytes (PMNS) from normal control subjects, family members with eczema (patients), the unaffected family member (PW), and eczema control subjects is compared. Normal plasma ( 0 ) or serum ( 0 ) was used as a source of chemotactic factors in all of these experiments. Each point represents the mean of duplicate determinations and group mean values are indicated by the horizontal bars. HPF: high power field. In Figure 3 , chemotactic migration of normal control PMN's was not significalitly different from eczema control PMN's, using normal plasm! as a source of chemotactic factors (X = 17.9, S D was strikingly ditferent ( P < 0.001) from patient PMN's, using normal plasma (X = 9.1 S D +-1.2) o r normal scrum (i = 8.2, S D 2 0.9) as a source of chemotactic factors. In the single family member without eczema o r infections ( P W ) PMN migration was intermediate between the control subjects and a_ll other affected family members, using either normal plasma (X = 13.3, S D + 2.1) or normal serum (X = 12.1, S D ? 2.2) as a source of chemotactic factors. The differences between group mcans for P W and control subjects were statistically significant (0.001 < P < 0.01). In these studies, the PMN's of all family membcrs except P W were tested on three separate occasions against normal plasma, normal scrum, or both plasma and scrum. PW's PMN's were tested four times.
SOURCE OF PMNS
Because of the differences in PMN migration of the affected family members and PW, a kinetic study was performed, comparing the migration of normal control PMN's, PMN's from D W (with defect), and from P W (intermediate defect). There was a linear relationship between chemotactic migration and time of incubation, up to 9 0 min; no differences were noted in the degree of PMN chemotaxis (Fig. 4) . From 90-180 min, however, DW's cells showed no further migration, whereas control and P W cells continued to migrate.
Although not shown, mixing experiments between paticnt and normal control serum failed to demonstrate an inhibitor of chemotactic factor production of expression. Using control scrum as a source of chemotactic factors, control cells displayed normal migration when preincubatcd in either control or patient serum, ruling out a cell-directed serum inhibitory factor as the cause of deficient PMN chemotaxis in the affectcd family mcmbers.
DISCUSSION
We have demonstrated a defcct in the chemotaxis of pcriphera1 blood PMN's of both parents and three of four children in a single family afflicted with varying degrees of respiratory allcrgy, unusual onset of eczema in the first month of life, and recurrent bacterial skin infections. We believe that this constitutes a unique syndrome in this family. The chcmotactic defcct has persisted over the 2.5-year period of rcpcated study, minimizing the possible contribution of day to day variations in chemotaxis to the observed defect. In the only member of the family without eczema o r skin infections (PW), PMN chemotaxis was intcrmediate betwcen that demonstrated in the affectcd family members and the control subjects. In contrast to the findings in this family, INCUBATION TIME (rnin.1 Fig. 4 . The migration of polymorphonuclear leukocytes (PMNS) from a control subject, an affccted family member (DW), and the unaffected family member ( P W ) is compared during various incubation periods. A single normal scrum specimcn was used as the source of chcmotactic factors. HPF: high power ficld. eight children with comparable degrees of atopic cczema and recurrent skin infcctions of varying dcgrcc dcmonstratcd normal PMN chemotaxis. The inability of the affected family members' serum to inhibit chemotactic migration of control PMN's makes it unlikely that a cell-directed humoral inhibitor is the cause of the chemotactic defect. The difference in the chemotactic migration of P W S PMN's and those of his affected parents and three siblings was emphasized by the kinetic studies. Subtle but important differences in PMN migration may not be apparent unless kinetic or dose-response studies are performed in conjunction with standardizcd chemotactic assays (4).
Chcmotactic factor production from immune complex activated family members' plasma was normal. Chcmotactic factor production from activated family members' scrum was slightly reduced when compared to control subjects. The reasons for this diffcrcncc arc not clear, but may be rclated to the smallcr number of experiments performed with serum (tz = 8) as compared to plasma (n = 14), and one markedly reduced value for serum chemotactic factor production (e.g., 13.2). The reduction in serum chemotactic factors could not be accounted for by complement deficiency, as CH50 levels were normal in all of thc patients.
Of great interest was the idcntification of HLA-B12 at the B locus in all family members except PW. The two children known since infancy to be most scvcrely affected with cczema and recurrent infcctions are HLA identical (AW, RW) and homozygous for HLA-B12. Thcse data, together with the clinical observations and chcmotactic defect raises two important questions: ( I ) is there an association between the inhcritcd chemotactic defect and/or cczcma and HLA-B12; (2) must thc chemotactic defect and eczcma occur together to produce the full expression of the syndrornc?
If one hypothesizes that eczema is inheritcd as a dominant condition in this family and that both parents are heterozygous for this gene as well as for HLA-B12 (also a dominant gene), then the coincidcnce that P W would not have eczcma and not have HLA-B12 would occur by chance with an incidence of 0.10 (lod score method). The probability of the combined coincidence of ( I ) three childrcn with HLA-BI2 having cczema; ( 2 ) two children ho~nozygous for HLA-B12 having the most scvcrc eczema; (3) one child hcterozygous for HLA-B12 having lcss severe eczcma; and (4) one child without HLA-Bl2 having no eczcma occurring by chance is only 0.0078. It is thercfore possible that one determinant of this syndrome is a dominant gene for cczcma, associated with the HLA-B12 locus. The chemotactic dcfcct would then have to be inhcritcd as a scparate, dominant trait.
Since the chemotactic defect was fully cxprcsscd in all family members except PW, who has an intermediate chcmotactic dcfect without eczema or HLA-B12, an alternative explanation must be considered; the chemotactic defect is inhcrited as a dominant trait and is itself linked to HLA-B12. For this to have occurred, however, would have required a recombination (crossover) on PW's sixth chromosome, since hc has the chemotactic defect but no HLA-B12. The intermediate naturc of the chemotactic defect might be explained by the abscncc of eczema and recurrent infcctions. It has been suggested by Hill and Quie (7) and other studies from our laboratory (15) that cczcma may aggravate or enhance cellular chemotactic defects, perhaps through dcfccts in the local inflammatory rcsponsc. Although chromosomal recombination is well described in the mouse (2). it has not been studied in man. It seems more likely that the former hypothesis is correct, and that the full phenotypic cxprcssion of the syndrome requires at least the combination of eczema and a chemotactic defcct. It is possible that othcr as yet unknown determinants associated with HLA-B12 are playing a role in this syndrome.
It is important to emphasize that our assumptions are bascd on a small family pedigree. However, the unavailability of othcr pertinent family members for study prevents a more thorough testing of these hypotheses.
The association of various diseases with specific HLA antigens is well known, but must be distinguished from disorders that occur in families with a specific haplotype (5). Levine et al. (10) have reported the association of specific HLA haplotypes with ragweed pollen allergy in seven families, implying "close genetic linkage between the HLA system and a genetic locus controlling immune responsiveness to antigen E." In this family, however, no particular haplotype could be associated with clinical ragweed allergy or specific IgE antibody to antigen E.
On the basis of our data we are unable to relate hyperimmunoglobulinemia E per se to either eczema or the chemotactic defect. Patients with atopic eczema often have elevated IgE levels, but the converse is not the case. Defects in chemotaxis have been reported in relatively few individuals with eczema and increased IgE levels. All of our eight eczema control subjects had normal chemotaxis, but four out of eight had elevated IgE levels. Hill and Quie (7) have pointed out that not all patients with elevated IgE have defective chemotaxis.
There are many similarities in the clinical and laboratory findings between our patients and those reported by Hill and Quie (6), although their patients were unrelated. The clinical and laboratory evidence for reaginic hypersensitivity was substantial. Associated immunologic defects were not detected in either group of patients. The different features of our family were the familial nature of the chemotactic defect, possible association of symptoms with a distinct HLA antigen, and the identification of a partial or intermediate defect in the PMN's of PW, who does not have this antigen.
The defect present in this family is different from that recently discovered in another family and reported from this laboratory (13). Those patients suffered from congenital ichthyosis and recurrent tinea rubrum infections, clinical and laboratory evidence of atopy was absent, and the defect was present in only one parent. Two additional recent reports of familial chemotactic defects should be mentioned. Van Scoy et al. (1 7) described recurrent bacterial infections, chronic mucocutaneous candidiasis, and extreme hyperimmunoglobulinemia E in association with defective neutrophil chemotaxis and lymphocyte responses to Candida antigen in a mother and her daughter. Family studies suggested a familial pattern of hyperimmunoglobulinemia E and defective chemotaxis. The mother but not the daughter had atopy. HLA typing was not performed. Witemeyer and Van Epps (18) described a neutrophil chemotactic defect in two of six siblings who also suffered from recurrent infections and were red headed. Although none of the three published family studies are strictly comparable to each other or to our own, it is clear that familial defects of neutrophil chemotaxis are of growing importance in delineating the causes of syndromes of recurrent infection afflicting multiple family members.
The link between in virro defects of chemotaxis and recurrent bacterial infections remains a controversial and unresolved issue, in the absence of consistent in vivo correlates of leukotactic defects (1 1). In one of our affected patients (DW), PMN counts, in vivo migration of PMN's (Rebuck window), and mobilization of PMN's from the bone marrow and marginal pools were normal. Nevertheless, the familial nature of this in virro defect and its correlation with a distinct clinical syndrome strongly suggests a cause and effect relationship. CONCLUSION A familial defect of neutrophil chemotaxis is described affecting both parents and three of four children. The fourth child has a pattern of chemotactic migration intermediate between affected family members and control subjects. The complete chemotactic defect is associated with a distinct clinical syndrome of respiratory allergy, very early onset of eczema (e.g., first month of life), recurrent skin infections, and also with HLA-B12. The fourth child is clinically well and does not have HLA-B12. All other tests of immune function are normal in all family members. We postulate an association between two dominantly inherited genes (e.g., eczema and HLA-B12) and the separate inheritance of the chemotactic defect. However, full expression of the clinical syndrome requires the coexistence of eczema and the chemotactic defect.
